Structure

Physi-Chem Properties

Molecular Weight:  592.26
Volume:  611.778
LogP:  6.079
LogD:  3.859
LogS:  -7.047
# Rotatable Bonds:  3
TPSA:  81.98
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  8
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.284
Synthetic Accessibility Score:  5.632
Fsp3:  0.306
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.826
MDCK Permeability:  1.857494680734817e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.955
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.031
30% Bioavailability (F30%):  0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.265
Plasma Protein Binding (PPB):  95.16092681884766%
Volume Distribution (VD):  0.617
Pgp-substrate:  2.2791521549224854%

ADMET: Metabolism

CYP1A2-inhibitor:  0.088
CYP1A2-substrate:  0.955
CYP2C19-inhibitor:  0.158
CYP2C19-substrate:  0.919
CYP2C9-inhibitor:  0.096
CYP2C9-substrate:  0.65
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.932
CYP3A4-inhibitor:  0.107
CYP3A4-substrate:  0.943

ADMET: Excretion

Clearance (CL):  7.921
Half-life (T1/2):  0.18

ADMET: Toxicity

hERG Blockers:  0.918
Human Hepatotoxicity (H-HT):  0.045
Drug-inuced Liver Injury (DILI):  0.753
AMES Toxicity:  0.147
Rat Oral Acute Toxicity:  0.445
Maximum Recommended Daily Dose:  0.983
Skin Sensitization:  0.769
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.005
Respiratory Toxicity:  0.613

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC41122

Natural Product ID:  NPC41122
Common Name*:   FKHCVUFZOFEROS-MUUNZHRXSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  FKHCVUFZOFEROS-MUUNZHRXSA-N
Standard InCHI:  InChI=1S/C36H36N2O6/c1-38-14-12-23-18-31(40-2)32-20-26(23)28(38)16-22-7-10-29(39)30(17-22)43-25-8-5-21(6-9-25)15-27-34-24(11-13-37-27)19-33(41-3)35(42-4)36(34)44-32/h5-10,17-20,28,39H,11-16H2,1-4H3/t28-/m1/s1
SMILES:  COc1cc2CCN([C@H]3c2cc1Oc1c2C(=NCCc2cc(c1OC)OC)Cc1ccc(Oc2cc(C3)ccc2O)cc1)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1967074
PubChem CID:   6711179
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. DOI[10.1016/S0040-4039(99)00339-1]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. PMID[10746886]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. PMID[10757718]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota root bark Kunming, Yunnan, China n.a. PMID[10757718]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[10757718]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota Aerial parts n.a. n.a. PMID[20426456]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[22256754]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. PMID[22256754]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. PMID[23252270]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[2534610]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Europe PMC[535601]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[8328267]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[9392886]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[Article]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. leaf n.a. Database[Article]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. root n.a. Database[Article]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[Phytochemistry, 2000, 53, 715-722.]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[Title]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota root bark n.a. n.a. Database[Title]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota root bark Kunming, Yunnan, China n.a. Database[Title]
NPO1152 Tripterygium hypoglaucum Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11351 Stephania japonica Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT367 Cell Line MDA-N Homo sapiens GI50 n.a. 16634.13 nM PMID[450352]
NPT368 Cell Line SN12C Homo sapiens GI50 n.a. 22908.68 nM PMID[450352]
NPT369 Cell Line ACHN Homo sapiens GI50 n.a. 23120.65 nM PMID[450352]
NPT370 Cell Line NCI-H23 Homo sapiens GI50 n.a. 19098.53 nM PMID[450352]
NPT372 Cell Line HOP-92 Homo sapiens GI50 n.a. 13551.89 nM PMID[450352]
NPT116 Cell Line HL-60 Homo sapiens GI50 n.a. 13995.87 nM PMID[450352]
NPT90 Cell Line DU-145 Homo sapiens GI50 n.a. 25351.29 nM PMID[450352]
NPT373 Cell Line SK-MEL-5 Homo sapiens GI50 n.a. 12218.0 nM PMID[450352]
NPT374 Cell Line SF-539 Homo sapiens GI50 n.a. 14757.07 nM PMID[450352]
NPT375 Cell Line Malme-3M Homo sapiens GI50 n.a. 601.17 nM PMID[450352]
NPT111 Cell Line K562 Homo sapiens GI50 n.a. 12735.03 nM PMID[450352]
NPT376 Cell Line A498 Homo sapiens GI50 n.a. 22029.26 nM PMID[450352]
NPT112 Cell Line MOLT-4 Homo sapiens GI50 n.a. 11885.02 nM PMID[450352]
NPT377 Cell Line OVCAR-3 Homo sapiens GI50 n.a. 17741.89 nM PMID[450352]
NPT378 Cell Line NCI/ADR-RES Homo sapiens GI50 n.a. 13583.13 nM PMID[450352]
NPT379 Cell Line HOP-62 Homo sapiens GI50 n.a. 22335.72 nM PMID[450352]
NPT381 Cell Line OVCAR-8 Homo sapiens GI50 n.a. 16032.45 nM PMID[450352]
NPT380 Cell Line U-251 Homo sapiens GI50 n.a. 17418.07 nM PMID[450352]
NPT382 Cell Line OVCAR-5 Homo sapiens GI50 n.a. 45603.69 nM PMID[450352]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 n.a. 12941.96 nM PMID[450352]
NPT383 Cell Line SNB-19 Homo sapiens GI50 n.a. 23442.29 nM PMID[450352]
NPT385 Cell Line SR Homo sapiens GI50 n.a. 5741.16 nM PMID[450352]
NPT384 Cell Line TK-10 Homo sapiens GI50 n.a. 20606.3 nM PMID[450352]
NPT323 Cell Line SW-620 Homo sapiens GI50 n.a. 17258.38 nM PMID[450352]
NPT386 Cell Line KM12 Homo sapiens GI50 n.a. 15031.42 nM PMID[450352]
NPT455 Cell Line NCI-H522 Homo sapiens GI50 n.a. 10690.55 nM PMID[450352]
NPT388 Cell Line NCI-H322M Homo sapiens GI50 n.a. 18407.72 nM PMID[450352]
NPT387 Cell Line M14 Homo sapiens GI50 n.a. 16255.49 nM PMID[450352]
NPT389 Cell Line RPMI-8226 Homo sapiens GI50 n.a. 16330.52 nM PMID[450352]
NPT456 Cell Line OVCAR-4 Homo sapiens GI50 n.a. 16106.46 nM PMID[450352]
NPT390 Cell Line LOX IMVI Homo sapiens GI50 n.a. 12589.25 nM PMID[450352]
NPT457 Cell Line BT-549 Homo sapiens GI50 n.a. 12473.84 nM PMID[450352]
NPT147 Cell Line SK-MEL-2 Homo sapiens GI50 n.a. 16749.43 nM PMID[450352]
NPT391 Cell Line HCC 2998 Homo sapiens GI50 n.a. 13365.96 nM PMID[450352]
NPT81 Cell Line A549 Homo sapiens GI50 n.a. 37497.3 nM PMID[450352]
NPT392 Cell Line SNB-75 Homo sapiens GI50 n.a. 14125.38 nM PMID[450352]
NPT393 Cell Line HCT-116 Homo sapiens GI50 n.a. 12022.64 nM PMID[450352]
NPT148 Cell Line HCT-15 Homo sapiens GI50 n.a. 12189.9 nM PMID[450352]
NPT394 Cell Line EKVX Homo sapiens GI50 n.a. 23227.37 nM PMID[450352]
NPT395 Cell Line SF-268 Homo sapiens GI50 n.a. 22594.36 nM PMID[450352]
NPT83 Cell Line MCF7 Homo sapiens GI50 n.a. 25763.21 nM PMID[450352]
NPT306 Cell Line PC-3 Homo sapiens GI50 n.a. 13243.42 nM PMID[450352]
NPT146 Cell Line SK-OV-3 Homo sapiens GI50 n.a. 48640.72 nM PMID[450352]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 n.a. 15595.53 nM PMID[450352]
NPT396 Cell Line T47D Homo sapiens GI50 n.a. 21037.78 nM PMID[450352]
NPT398 Cell Line UACC-62 Homo sapiens GI50 n.a. 16672.47 nM PMID[450352]
NPT308 Cell Line CAKI-1 Homo sapiens GI50 n.a. 20558.91 nM PMID[450352]
NPT399 Cell Line SF-295 Homo sapiens GI50 n.a. 19364.22 nM PMID[450352]
NPT400 Cell Line MDA-MB-435 Homo sapiens GI50 n.a. 18450.15 nM PMID[450352]
NPT458 Cell Line IGROV-1 Homo sapiens GI50 n.a. 25351.29 nM PMID[450352]
NPT402 Cell Line Hs-578T Homo sapiens GI50 n.a. 17619.76 nM PMID[450352]
NPT401 Cell Line 786-0 Homo sapiens GI50 n.a. 10447.2 nM PMID[450352]
NPT403 Cell Line UACC-257 Homo sapiens GI50 n.a. 15995.58 nM PMID[450352]
NPT404 Cell Line CCRF-CEM Homo sapiens GI50 n.a. 29991.63 nM PMID[450352]
NPT139 Cell Line HT-29 Homo sapiens GI50 n.a. 10814.34 nM PMID[450352]
NPT405 Cell Line NCI-H226 Homo sapiens GI50 n.a. 22594.36 nM PMID[450352]
NPT170 Cell Line SK-MEL-28 Homo sapiens GI50 n.a. 16710.91 nM PMID[450352]
NPT406 Cell Line RXF 393 Homo sapiens GI50 n.a. 10023.05 nM PMID[450352]
NPT407 Cell Line COLO 205 Homo sapiens GI50 n.a. 13489.63 nM PMID[450352]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC41122 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC318805
0.977 High Similarity NPC234318
0.9769 High Similarity NPC85381
0.9588 High Similarity NPC195538
0.9532 High Similarity NPC476202
0.9422 High Similarity NPC249996
0.936 High Similarity NPC286119
0.9306 High Similarity NPC223690
0.9306 High Similarity NPC49075
0.9306 High Similarity NPC328155
0.9306 High Similarity NPC42663
0.9306 High Similarity NPC311973
0.9306 High Similarity NPC90998
0.9306 High Similarity NPC30779
0.9306 High Similarity NPC258657
0.9306 High Similarity NPC7715
0.9306 High Similarity NPC15414
0.9306 High Similarity NPC290005
0.9306 High Similarity NPC54654
0.9306 High Similarity NPC285931
0.9306 High Similarity NPC279228
0.9306 High Similarity NPC239824
0.9306 High Similarity NPC104196
0.9306 High Similarity NPC290582
0.9306 High Similarity NPC185639
0.9306 High Similarity NPC181796
0.9306 High Similarity NPC271013
0.9306 High Similarity NPC8836
0.9306 High Similarity NPC217748
0.9306 High Similarity NPC182052
0.9306 High Similarity NPC222661
0.9306 High Similarity NPC251735
0.9306 High Similarity NPC229373
0.9253 High Similarity NPC274716
0.9253 High Similarity NPC254441
0.9253 High Similarity NPC167116
0.9148 High Similarity NPC212237
0.9148 High Similarity NPC116465
0.9096 High Similarity NPC22115
0.9096 High Similarity NPC275680
0.9045 High Similarity NPC175890
0.9045 High Similarity NPC11296
0.9045 High Similarity NPC82457
0.9045 High Similarity NPC274661
0.9045 High Similarity NPC48490
0.9045 High Similarity NPC206900
0.8994 High Similarity NPC191132
0.8994 High Similarity NPC60295
0.8983 High Similarity NPC95426
0.8983 High Similarity NPC16357
0.8983 High Similarity NPC302245
0.8944 High Similarity NPC24260
0.8944 High Similarity NPC478093
0.8933 High Similarity NPC139783
0.8933 High Similarity NPC65312
0.8902 High Similarity NPC276890
0.8902 High Similarity NPC76682
0.8902 High Similarity NPC317145
0.8902 High Similarity NPC10908
0.8902 High Similarity NPC198498
0.8902 High Similarity NPC63646
0.8902 High Similarity NPC317439
0.8902 High Similarity NPC115284
0.8902 High Similarity NPC227060
0.8895 High Similarity NPC473589
0.8895 High Similarity NPC30182
0.8895 High Similarity NPC478092
0.8895 High Similarity NPC478091
0.8851 High Similarity NPC12424
0.8851 High Similarity NPC41376
0.8851 High Similarity NPC129518
0.8851 High Similarity NPC251580
0.8786 High Similarity NPC83198
0.8786 High Similarity NPC204908
0.8779 High Similarity NPC317272
0.8779 High Similarity NPC240841
0.8779 High Similarity NPC250846
0.8779 High Similarity NPC42549
0.8779 High Similarity NPC256012
0.8779 High Similarity NPC268503
0.875 High Similarity NPC293093
0.8689 High Similarity NPC256124
0.8678 High Similarity NPC66573
0.8671 High Similarity NPC264850
0.8671 High Similarity NPC13916
0.8656 High Similarity NPC475654
0.8652 High Similarity NPC243454
0.8652 High Similarity NPC475479
0.8636 High Similarity NPC190783
0.8636 High Similarity NPC232386
0.8636 High Similarity NPC152680
0.8613 High Similarity NPC24465
0.8603 High Similarity NPC239584
0.8556 High Similarity NPC299990
0.8556 High Similarity NPC73492
0.8533 High Similarity NPC476565
0.8508 High Similarity NPC302275
0.8478 Intermediate Similarity NPC223236
0.8478 Intermediate Similarity NPC259350
0.8475 Intermediate Similarity NPC108434
0.8475 Intermediate Similarity NPC475215
0.8475 Intermediate Similarity NPC239775
0.8421 Intermediate Similarity NPC107602
0.8418 Intermediate Similarity NPC168753
0.8418 Intermediate Similarity NPC118274
0.8372 Intermediate Similarity NPC247639
0.8372 Intermediate Similarity NPC25084
0.8371 Intermediate Similarity NPC231371
0.8325 Intermediate Similarity NPC254581
0.8324 Intermediate Similarity NPC281581
0.8315 Intermediate Similarity NPC14507
0.8315 Intermediate Similarity NPC47077
0.8289 Intermediate Similarity NPC471113
0.8286 Intermediate Similarity NPC50380
0.8286 Intermediate Similarity NPC179250
0.828 Intermediate Similarity NPC475597
0.828 Intermediate Similarity NPC473716
0.8276 Intermediate Similarity NPC216816
0.8276 Intermediate Similarity NPC329837
0.8246 Intermediate Similarity NPC127402
0.8242 Intermediate Similarity NPC474507
0.8208 Intermediate Similarity NPC249797
0.8208 Intermediate Similarity NPC184026
0.8208 Intermediate Similarity NPC469817
0.8208 Intermediate Similarity NPC295691
0.8208 Intermediate Similarity NPC276588
0.8208 Intermediate Similarity NPC278799
0.8208 Intermediate Similarity NPC5238
0.8208 Intermediate Similarity NPC39701
0.8208 Intermediate Similarity NPC172765
0.8208 Intermediate Similarity NPC127674
0.8208 Intermediate Similarity NPC189266
0.8208 Intermediate Similarity NPC110416
0.8208 Intermediate Similarity NPC54379
0.8208 Intermediate Similarity NPC2413
0.8208 Intermediate Similarity NPC193949
0.8208 Intermediate Similarity NPC207757
0.8208 Intermediate Similarity NPC204828
0.8202 Intermediate Similarity NPC474931
0.8202 Intermediate Similarity NPC81218
0.8202 Intermediate Similarity NPC158376
0.8202 Intermediate Similarity NPC117188
0.8202 Intermediate Similarity NPC205421
0.8202 Intermediate Similarity NPC306555
0.8202 Intermediate Similarity NPC145832
0.8202 Intermediate Similarity NPC12053
0.8192 Intermediate Similarity NPC212794
0.8192 Intermediate Similarity NPC13504
0.8192 Intermediate Similarity NPC253043
0.8192 Intermediate Similarity NPC136508
0.8192 Intermediate Similarity NPC477563
0.8192 Intermediate Similarity NPC306843
0.8192 Intermediate Similarity NPC96603
0.8192 Intermediate Similarity NPC78222
0.8192 Intermediate Similarity NPC196447
0.8182 Intermediate Similarity NPC60186
0.8176 Intermediate Similarity NPC428
0.8176 Intermediate Similarity NPC147390
0.8176 Intermediate Similarity NPC246587
0.8176 Intermediate Similarity NPC24233
0.8176 Intermediate Similarity NPC135538
0.8176 Intermediate Similarity NPC476571
0.8155 Intermediate Similarity NPC201508
0.8146 Intermediate Similarity NPC68328
0.8136 Intermediate Similarity NPC475393
0.8136 Intermediate Similarity NPC324144
0.8132 Intermediate Similarity NPC173416
0.8132 Intermediate Similarity NPC148709
0.8132 Intermediate Similarity NPC476577
0.8129 Intermediate Similarity NPC477565
0.8129 Intermediate Similarity NPC103379
0.8125 Intermediate Similarity NPC119649
0.8125 Intermediate Similarity NPC235143
0.8125 Intermediate Similarity NPC230956
0.8125 Intermediate Similarity NPC205255
0.8125 Intermediate Similarity NPC271388
0.8118 Intermediate Similarity NPC179825
0.8118 Intermediate Similarity NPC191376
0.8118 Intermediate Similarity NPC321505
0.8081 Intermediate Similarity NPC220858
0.8081 Intermediate Similarity NPC192768
0.8081 Intermediate Similarity NPC97221
0.8081 Intermediate Similarity NPC88249
0.8081 Intermediate Similarity NPC151895
0.8079 Intermediate Similarity NPC79402
0.8079 Intermediate Similarity NPC80759
0.8077 Intermediate Similarity NPC96584
0.8077 Intermediate Similarity NPC255800
0.8068 Intermediate Similarity NPC221864
0.8066 Intermediate Similarity NPC10871
0.8045 Intermediate Similarity NPC90984
0.8035 Intermediate Similarity NPC476568
0.8034 Intermediate Similarity NPC1229
0.8023 Intermediate Similarity NPC27410
0.8023 Intermediate Similarity NPC166014
0.8012 Intermediate Similarity NPC476151
0.8011 Intermediate Similarity NPC195766
0.8011 Intermediate Similarity NPC206736
0.8 Intermediate Similarity NPC185838
0.797 Intermediate Similarity NPC82056

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC41122 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9306 High Similarity NPD8054 Approved
0.9306 High Similarity NPD8053 Approved
0.8902 High Similarity NPD8251 Approved
0.8902 High Similarity NPD8252 Approved
0.8902 High Similarity NPD8099 Discontinued
0.8851 High Similarity NPD8156 Discontinued
0.8034 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.8021 Intermediate Similarity NPD8095 Phase 1
0.7966 Intermediate Similarity NPD6788 Approved
0.7931 Intermediate Similarity NPD4005 Discontinued
0.7926 Intermediate Similarity NPD7906 Approved
0.7849 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD4584 Approved
0.7784 Intermediate Similarity NPD4678 Approved
0.7784 Intermediate Similarity NPD4675 Approved
0.7772 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7747 Intermediate Similarity NPD6071 Discontinued
0.7722 Intermediate Similarity NPD7831 Phase 2
0.7722 Intermediate Similarity NPD7833 Phase 2
0.7722 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD4055 Discovery
0.7717 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7713 Intermediate Similarity NPD7312 Approved
0.7713 Intermediate Similarity NPD7313 Approved
0.7713 Intermediate Similarity NPD7310 Approved
0.7713 Intermediate Similarity NPD7311 Approved
0.7701 Intermediate Similarity NPD7447 Phase 1
0.7672 Intermediate Similarity NPD7309 Approved
0.7663 Intermediate Similarity NPD27 Approved
0.7663 Intermediate Similarity NPD2489 Approved
0.765 Intermediate Similarity NPD3051 Approved
0.7647 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4577 Approved
0.7619 Intermediate Similarity NPD4578 Approved
0.7609 Intermediate Similarity NPD2969 Approved
0.7609 Intermediate Similarity NPD2970 Approved
0.7592 Intermediate Similarity NPD4663 Approved
0.7572 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD7213 Phase 3
0.7543 Intermediate Similarity NPD7212 Phase 2
0.7542 Intermediate Similarity NPD4773 Phase 2
0.7542 Intermediate Similarity NPD4772 Phase 2
0.7527 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD2560 Approved
0.7514 Intermediate Similarity NPD2563 Approved
0.75 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7298 Approved
0.75 Intermediate Similarity NPD4123 Phase 3
0.7474 Intermediate Similarity NPD7549 Discontinued
0.7461 Intermediate Similarity NPD7291 Discontinued
0.7459 Intermediate Similarity NPD5772 Approved
0.7459 Intermediate Similarity NPD4010 Discontinued
0.7459 Intermediate Similarity NPD5773 Approved
0.7382 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD2898 Approved
0.7348 Intermediate Similarity NPD6072 Discontinued
0.7345 Intermediate Similarity NPD2421 Approved
0.7345 Intermediate Similarity NPD2420 Approved
0.733 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD3692 Discontinued
0.7318 Intermediate Similarity NPD2122 Discontinued
0.7318 Intermediate Similarity NPD6031 Approved
0.7318 Intermediate Similarity NPD6030 Approved
0.7308 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD1424 Approved
0.7294 Intermediate Similarity NPD2674 Phase 3
0.7288 Intermediate Similarity NPD7124 Phase 2
0.7283 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD5677 Discontinued
0.7238 Intermediate Similarity NPD4017 Approved
0.7238 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD5241 Discontinued
0.7228 Intermediate Similarity NPD3450 Approved
0.7228 Intermediate Similarity NPD2493 Approved
0.7228 Intermediate Similarity NPD3452 Approved
0.7228 Intermediate Similarity NPD2494 Approved
0.7219 Intermediate Similarity NPD7802 Discontinued
0.7212 Intermediate Similarity NPD7827 Phase 1
0.7211 Intermediate Similarity NPD7493 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2490 Approved
0.7208 Intermediate Similarity NPD2488 Approved
0.7196 Intermediate Similarity NPD4481 Phase 3
0.7191 Intermediate Similarity NPD3845 Phase 1
0.7189 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD6331 Phase 2
0.7158 Intermediate Similarity NPD5089 Approved
0.7158 Intermediate Similarity NPD5090 Approved
0.715 Intermediate Similarity NPD6997 Phase 2
0.7136 Intermediate Similarity NPD7263 Phase 2
0.7135 Intermediate Similarity NPD3145 Approved
0.7135 Intermediate Similarity NPD3144 Approved
0.7128 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD4582 Approved
0.7122 Intermediate Similarity NPD4583 Approved
0.7114 Intermediate Similarity NPD7034 Discontinued
0.7109 Intermediate Similarity NPD7047 Phase 3
0.7093 Intermediate Similarity NPD7477 Discontinued
0.7073 Intermediate Similarity NPD4002 Approved
0.7073 Intermediate Similarity NPD4004 Approved
0.7072 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD6377 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7153 Discontinued
0.7059 Intermediate Similarity NPD8070 Approved
0.7059 Intermediate Similarity NPD5604 Discontinued
0.7049 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD5718 Phase 2
0.7033 Intermediate Similarity NPD3640 Phase 3
0.7033 Intermediate Similarity NPD3641 Approved
0.7033 Intermediate Similarity NPD3639 Approved
0.703 Intermediate Similarity NPD2973 Approved
0.703 Intermediate Similarity NPD2975 Approved
0.703 Intermediate Similarity NPD2974 Approved
0.7022 Intermediate Similarity NPD5177 Phase 3
0.702 Intermediate Similarity NPD6841 Approved
0.702 Intermediate Similarity NPD6843 Phase 3
0.702 Intermediate Similarity NPD6842 Approved
0.7018 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD7773 Phase 2
0.7 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4474 Approved
0.6994 Remote Similarity NPD4475 Approved
0.699 Remote Similarity NPD5917 Clinical (unspecified phase)
0.6983 Remote Similarity NPD6748 Discontinued
0.6983 Remote Similarity NPD7466 Approved
0.6979 Remote Similarity NPD3489 Phase 3
0.6978 Remote Similarity NPD7526 Approved
0.6978 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6978 Remote Similarity NPD52 Approved
0.6973 Remote Similarity NPD7438 Suspended
0.6959 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6503 Clinical (unspecified phase)
0.6954 Remote Similarity NPD1613 Approved
0.6954 Remote Similarity NPD6851 Approved
0.6954 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6853 Approved
0.695 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6949 Remote Similarity NPD1632 Clinical (unspecified phase)
0.6948 Remote Similarity NPD8149 Discontinued
0.6947 Remote Similarity NPD6107 Approved
0.6942 Remote Similarity NPD5005 Approved
0.6942 Remote Similarity NPD5006 Approved
0.6932 Remote Similarity NPD2200 Suspended
0.6927 Remote Similarity NPD4580 Approved
0.6923 Remote Similarity NPD6297 Approved
0.6919 Remote Similarity NPD4908 Phase 1
0.691 Remote Similarity NPD3656 Approved
0.6907 Remote Similarity NPD6042 Phase 2
0.6907 Remote Similarity NPD42 Phase 2
0.6904 Remote Similarity NPD2971 Approved
0.6904 Remote Similarity NPD2968 Approved
0.6904 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6885 Remote Similarity NPD6090 Discontinued
0.6882 Remote Similarity NPD3778 Approved
0.6878 Remote Similarity NPD3837 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4083 Discontinued
0.6872 Remote Similarity NPD3920 Phase 2
0.6863 Remote Similarity NPD4605 Approved
0.6863 Remote Similarity NPD6621 Clinical (unspecified phase)
0.6863 Remote Similarity NPD4604 Approved
0.6854 Remote Similarity NPD2161 Phase 2
0.6852 Remote Similarity NPD8318 Clinical (unspecified phase)
0.6851 Remote Similarity NPD2219 Phase 1
0.685 Remote Similarity NPD7243 Clinical (unspecified phase)
0.6845 Remote Similarity NPD5722 Discontinued
0.684 Remote Similarity NPD8153 Approved
0.684 Remote Similarity NPD8152 Approved
0.6839 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6836 Remote Similarity NPD6111 Discontinued
0.6836 Remote Similarity NPD6895 Approved
0.6836 Remote Similarity NPD6896 Approved
0.6833 Remote Similarity NPD3060 Approved
0.6832 Remote Similarity NPD3922 Approved
0.6832 Remote Similarity NPD3923 Approved
0.6832 Remote Similarity NPD3921 Approved
0.6832 Remote Similarity NPD3924 Approved
0.6831 Remote Similarity NPD7019 Approved
0.6831 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6831 Remote Similarity NPD7020 Approved
0.6829 Remote Similarity NPD4420 Approved
0.6823 Remote Similarity NPD4606 Clinical (unspecified phase)
0.6816 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6816 Remote Similarity NPD2843 Phase 2
0.6816 Remote Similarity NPD2845 Phase 2
0.6813 Remote Similarity NPD6666 Approved
0.6813 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6813 Remote Similarity NPD6667 Approved
0.6811 Remote Similarity NPD5267 Discontinued
0.681 Remote Similarity NPD7222 Phase 2
0.6809 Remote Similarity NPD2977 Approved
0.6809 Remote Similarity NPD4585 Approved
0.6809 Remote Similarity NPD2978 Approved
0.6809 Remote Similarity NPD7169 Suspended
0.6806 Remote Similarity NPD6746 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data